Abstract
Transcutaneous cardiac pacing is a lifesaving procedure for patients with certain types of unstable bradycardia. The American Heart Association (AHA) guidelines for the management of unstable bradycardia recommend initiating transcutaneous pacing in patients unresponsive to atropine while addressing the primary cause of the bradycardia. Current major resuscitation guidelines do not address which pacer pad position to use. The aim of this study was to assess the difference in the pacing thresholds between the anteroposterior (AP) and anterolateral (AL) pacer pad positions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
